Universities and research institutes at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
15 universities and research institutes are at Cell 2026 — 22 presentations on the program. Most represented: King's College London (2 on the program), John Radcliffe Hospital (1 on the program), Technical University of Denmark (1 on the program). 7 of them have their own page in this guide. As of Oct 8, 2026.
Topic
Top represented
Showing 1–15 of 15 organizations
| Organization | Cell 2026 Attendance |
|---|---|
King's College London London, UK | |
London research university with cell and gene therapy research groups and a gene therapy vector manufacturing facility. | Talk Thu Nov 12 4:55pm–5:20pm Lentiviral Vector As Drug Product – A Gene Therapy Vector Facility Case Study Cell and gene therapyManufacturing and CMC Talk Fri Nov 13 1:55pm–2:20pm Hindsight is 20/20: Lessons Learned From Developing A Retinal Cell Therapy Cell and gene therapy |
John Radcliffe Hospital Oxford, UK | |
Oxford teaching hospital, part of Oxford University Hospitals NHS Foundation Trust. | Panel Fri Nov 13 2:45pm–3:10pm From Approval To Access: Why Cell & Gene Therapies Still Don’t Reach Patients Cell and gene therapy Talk Fri Nov 13 3:10pm–3:35pm Donor Perspectives Of Advanced Therapies Development Cell and gene therapy |
Technical University of Denmark Kongens Lyngby, Denmark | |
Danish technical university with research in biotechnology, bioprocess engineering and cell line engineering. | Talk Thu Nov 12 4:55pm–5:20pm Minimised Process Development By Recombinase Based Targeted Insertion For Superfast Clone Development Allowing Prefabricated Manufacturing Process Cell line developmentManufacturing and CMC Panel Fri Nov 13 1:55pm–2:20pm Closing The Gap: Connecting Upstream And Downstream Bioprocessing In Cell-Based Therapies Cell culture and upstream processingCell and gene therapy |
University Medical Center Freiburg Freiburg, Germany | |
University hospital and medical research centre of the University of Freiburg. | Talk Thu Nov 12 10:15am–10:40am Panel Thu Nov 12 12:25pm–12:50pm Cracking In Vivo Delivery For Next-Generation Gene Therapies Cell and gene therapy |
University of Cambridge Cambridge, UK | |
Research university whose clinical research includes gene and cell therapies to restore hearing. | Talk Thu Nov 12 3:05pm–3:30pm Gene Therapy For Hearing Loss Cell and gene therapy Panel Thu Nov 12 5:45pm–6:10pm |
University of Liverpool Liverpool, UK | |
Research university with work on quality control and potency testing for cell therapies. | Panel Thu Nov 12 2:40pm–3:05pm Quality Control Strategies In Advanced CGTs Cell and gene therapyAnalytics and characterization Talk Thu Nov 12 5:45pm–6:10pm Choice Of Potency Assays For Vascular Cell Therapies Analytics and characterizationCell and gene therapy |
University of Sheffield Sheffield, UK | |
Research university with biopharmaceutical engineering work on cell, vector and media engineering for hard-to-produce biologics. | Panel Thu Nov 12 12:25pm–12:50pm Manufacturing Next-Generation Therapeutic Modalities Manufacturing and CMC Talk Thu Nov 12 2:40pm–3:05pm Cell, Vector And Media Engineering To Facilitate Manufacture Of ‘Difficult-To-Express’ Products Cell line developmentCell culture and upstream processing |
CA CRUK-AstraZeneca Antibody Alliance Laboratory | |
Joint Cancer Research UK and AstraZeneca lab that develops antibodies against cancer targets put forward by academic researchers. | Talk Thu Nov 12 10:15am–10:40am Vector Design As The Strategic Lever In Biologics Development Cell line development |
Greater Paris University Hospitals (AP-HP) Paris, France | |
Public university hospital network of the Paris region, running patient care, research and clinical trials including advanced therapies. | Talk Fri Nov 13 4:15pm–4:40pm The French Model Of ATMP Clinical Trials In Rare Diseases Cell and gene therapy |
Hungarian Academy of Sciences Budapest, Hungary | |
Hungary's national academy of sciences, a learned society linked to a network of research institutes. | Talk Fri Nov 13 3:50pm–4:15pm Stem Cell-Derived Organoid Research Supporting Advanced Therapies Stem cells, organoids and cell modelsCell and gene therapy |
Royal Free London NHS Foundation Trust London, UK | |
NHS hospital trust in north London whose cell, gene and tissue therapeutics centre manufactures early-phase advanced therapies. | Talk Fri Nov 13 2:45pm–3:10pm From First-in-GMP to 300+ Releases: Building QC into Early Phase ATMP Manufacture Cell and gene therapyAnalytics and characterization |
University College London London, UK | |
London research university whose biochemical engineering department works on bioprocessing and the manufacture of cell and gene therapies. | Talk Fri Nov 13 3:10pm–3:35pm Underpinning Advanced Therapy Development Using Microfluidic Approaches Cell and gene therapy |
University of Kent Canterbury, UK | |
Public university whose School of Biosciences researches recombinant protein production in cells, cell biology and neuroscience. | Panel Thu Nov 12 10:15am–10:40am What’s Next For Cell And Stem Cell Therapies? Challenges, Opportunities, And Clinical Translation Cell and gene therapyStem cells, organoids and cell models |
University of Minho Braga, Portugal | |
Portuguese public university whose health sciences research includes the stem cell secretome in nervous system injury and repair. | Talk Fri Nov 13 4:15pm–4:40pm Modulatory Action of Stem Cells Secretome in Injury and Degeneration of the Central Nervous System Stem cells, organoids and cell models |
Wyss Zurich Zurich, Switzerland | |
Translational accelerator of ETH Zurich and the University of Zurich moving regenerative medicine, robotics and medical device projects toward clinical use. | Talk Fri Nov 13 11:40am–12:05pm Translational Hurdles When Switching From R&D To Clinical Manufacturing Manufacturing and CMC |
Instantly find 20 buyers from universities and research institutes
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Cell 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction